Research led by the Royal Women's Hospital, Australia, has found that early intratracheal administration of budesonide mixed ...
William Northway Jr. first described bronchopulmonary dysplasia (BPD) in 1967. Even with the many advances in the care of neonatal respiratory diseases BPD has remained a problem, but the ...
In extremely preterm infants receiving surfactant, early intratracheal budesonide had little to no effect on survival free of ...
A new study published in the Respiratory Medicine journal revealed that preschool children born extremely preterm (at or ...
The following is a summary of “Social Determinants of Health and Timing of Tracheostomy for Severe Bronchopulmonary Dysplasia ...
Oak Hill Bio and Chiesi Group have enrolled the first European patient in a Phase IIb clinical study for their collaborative ...
Oak Hill Bio, Chiesi announce first European patient enrolled in phase 2b study of OHB-607 for prevention of BPD in premature infants: Parma, Italy Tuesday, November 5, 2024, 14:0 ...
About Bronchopulmonary Dysplasia in Europe (BPD) 3 BPD is the most common complication of prematurity, resulting in chronic lung disease affecting, on average, 40-50% of infants born at less than ...